Skip to content
★ Sign in to follow
劉

劉乃菁

順藥
Total declarations
2
Company
1
▲ Purchases (0 ops.)
—
▼ Sales (0 ops.)
—

Latest filing published 18 Dec 2023 for 順藥, €296k.

Insider track record

Disclosed buys
0
Disclosed sells
0
Signal history

No signal scores available.

劉乃菁: trading record in brief

All filings by 劉乃菁 on record concern 順藥. Between 8 September 2021 and 18 December 2023, the trades on record add up to 2 filings.

No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Compensation-driven entries like these are tracked, but they say little about how insiders judge the share price.

On 18 December 2023 came the latest disclosure, a transaction in 順藥. These figures are compiled from regulatory filings published by TWSE / TPEx (MOPS). They describe what insiders did and are not a recommendation.

Companies and markets linked to 劉乃菁

Open company profiles for insider transactions, fundamentals and analyst consensus when available.

Declarations2 total
  • ●
    ManagerExecutives順藥
    €296kest.0MOPS
    150,000 sharesShareTPExTWMOPS:6535:112/12/18:劉乃菁:1w1k6fg
  • ●
    ManagerExecutives順藥
    €103kest.0MOPS
    100,000 sharesShareTPExTWMOPS:6535:110/09/08:劉乃菁:109gyv9

2 of 2 declarations